Cargando…

Repetitive Transcranial Magnetic Stimulation for the Treatment of Resistant Depression: A Scoping Review

Treatment-resistant depression (TRD) is associated with significant disability, and due to its high prevalence, it results in a substantive socio-economic burden at a global level. TRD is the inability to accomplish and/or achieve remission after an adequate trial of antidepressant treatments. Studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Adu, Medard Kofi, Shalaby, Reham, Chue, Pierre, Agyapong, Vincent I. O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220129/
https://www.ncbi.nlm.nih.gov/pubmed/35735405
http://dx.doi.org/10.3390/bs12060195
_version_ 1784732296254849024
author Adu, Medard Kofi
Shalaby, Reham
Chue, Pierre
Agyapong, Vincent I. O.
author_facet Adu, Medard Kofi
Shalaby, Reham
Chue, Pierre
Agyapong, Vincent I. O.
author_sort Adu, Medard Kofi
collection PubMed
description Treatment-resistant depression (TRD) is associated with significant disability, and due to its high prevalence, it results in a substantive socio-economic burden at a global level. TRD is the inability to accomplish and/or achieve remission after an adequate trial of antidepressant treatments. Studies comparing repetitive transcranial magnetic stimulation (rTMS) with electroconvulsive therapy (ECT) and pharmacotherapy have revealed evidence of the therapeutic efficacy of rTMS in TRD. These findings suggest a crucial role for rTMS in the management of TRD. This article aims to conduct a comprehensive scoping review of the current literature concerning the use of rTMS and its therapeutic efficacy as a treatment modality for TRD. PubMed, PsycINFO, Medline, Embase, and Cinahl were used to identify important articles on rTMS for TRD. The search strategy was limited to English articles within the last five years of data publication. Articles were included if they reported on a completed randomized controlled trial (RCT) of rTMS intervention for TRD. The exclusion criteria involved studies with rTMS for the treatment of conditions other than TRD, and study and experimental protocols of rTMS on TRD. In total, 17 studies were eligible for inclusion in this review. The search strategy spanned studies published in the last five years, to the date of the data search (14 February 2022). The regional breakdown of the extracted studies was North American (n = 9), European (n = 5), Asian (n = 2) and Australian (n = 1). The applied frequencies of rTMS ranged from 5 Hz to 50 Hz, with stimulation intensities ranging from 80% MT to 120% MT. Overall, 16 out of the 17 studies suggested that rTMS treatment was effective, safe and tolerated in TRD. For patients with TRD, rTMS appears to provide significant benefits through the reduction of depressive symptoms, and while there is progressive evidence in support of the same, more research is needed in order to define standardized protocols of rTMS application in terms of localization, frequency, intensity, and pulse parameters.
format Online
Article
Text
id pubmed-9220129
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92201292022-06-24 Repetitive Transcranial Magnetic Stimulation for the Treatment of Resistant Depression: A Scoping Review Adu, Medard Kofi Shalaby, Reham Chue, Pierre Agyapong, Vincent I. O. Behav Sci (Basel) Review Treatment-resistant depression (TRD) is associated with significant disability, and due to its high prevalence, it results in a substantive socio-economic burden at a global level. TRD is the inability to accomplish and/or achieve remission after an adequate trial of antidepressant treatments. Studies comparing repetitive transcranial magnetic stimulation (rTMS) with electroconvulsive therapy (ECT) and pharmacotherapy have revealed evidence of the therapeutic efficacy of rTMS in TRD. These findings suggest a crucial role for rTMS in the management of TRD. This article aims to conduct a comprehensive scoping review of the current literature concerning the use of rTMS and its therapeutic efficacy as a treatment modality for TRD. PubMed, PsycINFO, Medline, Embase, and Cinahl were used to identify important articles on rTMS for TRD. The search strategy was limited to English articles within the last five years of data publication. Articles were included if they reported on a completed randomized controlled trial (RCT) of rTMS intervention for TRD. The exclusion criteria involved studies with rTMS for the treatment of conditions other than TRD, and study and experimental protocols of rTMS on TRD. In total, 17 studies were eligible for inclusion in this review. The search strategy spanned studies published in the last five years, to the date of the data search (14 February 2022). The regional breakdown of the extracted studies was North American (n = 9), European (n = 5), Asian (n = 2) and Australian (n = 1). The applied frequencies of rTMS ranged from 5 Hz to 50 Hz, with stimulation intensities ranging from 80% MT to 120% MT. Overall, 16 out of the 17 studies suggested that rTMS treatment was effective, safe and tolerated in TRD. For patients with TRD, rTMS appears to provide significant benefits through the reduction of depressive symptoms, and while there is progressive evidence in support of the same, more research is needed in order to define standardized protocols of rTMS application in terms of localization, frequency, intensity, and pulse parameters. MDPI 2022-06-17 /pmc/articles/PMC9220129/ /pubmed/35735405 http://dx.doi.org/10.3390/bs12060195 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Adu, Medard Kofi
Shalaby, Reham
Chue, Pierre
Agyapong, Vincent I. O.
Repetitive Transcranial Magnetic Stimulation for the Treatment of Resistant Depression: A Scoping Review
title Repetitive Transcranial Magnetic Stimulation for the Treatment of Resistant Depression: A Scoping Review
title_full Repetitive Transcranial Magnetic Stimulation for the Treatment of Resistant Depression: A Scoping Review
title_fullStr Repetitive Transcranial Magnetic Stimulation for the Treatment of Resistant Depression: A Scoping Review
title_full_unstemmed Repetitive Transcranial Magnetic Stimulation for the Treatment of Resistant Depression: A Scoping Review
title_short Repetitive Transcranial Magnetic Stimulation for the Treatment of Resistant Depression: A Scoping Review
title_sort repetitive transcranial magnetic stimulation for the treatment of resistant depression: a scoping review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220129/
https://www.ncbi.nlm.nih.gov/pubmed/35735405
http://dx.doi.org/10.3390/bs12060195
work_keys_str_mv AT adumedardkofi repetitivetranscranialmagneticstimulationforthetreatmentofresistantdepressionascopingreview
AT shalabyreham repetitivetranscranialmagneticstimulationforthetreatmentofresistantdepressionascopingreview
AT chuepierre repetitivetranscranialmagneticstimulationforthetreatmentofresistantdepressionascopingreview
AT agyapongvincentio repetitivetranscranialmagneticstimulationforthetreatmentofresistantdepressionascopingreview